X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1175) 1175
Publication (150) 150
Book Chapter (24) 24
Book Review (17) 17
Conference Proceeding (5) 5
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (913) 913
index medicus (553) 553
mastocytosis (504) 504
proto-oncogene proteins c-kit - genetics (475) 475
mutation (415) 415
female (414) 414
male (410) 410
systemic mastocytosis (376) 376
hematology (334) 334
adult (321) 321
animals (292) 292
middle aged (273) 273
c-kit (261) 261
immunology (224) 224
mast cells - pathology (224) 224
mastocytosis, systemic - genetics (217) 217
aged (211) 211
oncology (209) 209
mastocytosis - genetics (201) 201
mast cells (180) 180
mast cell disease (176) 176
leukemia (164) 164
mast cells - metabolism (162) 162
mice (157) 157
allergy (147) 147
classification (143) 143
imatinib mesylate (141) 141
mastocytosis, systemic - pathology (139) 139
diagnosis (138) 138
disease (135) 135
proto-oncogene proteins c-kit - metabolism (134) 134
mastocytosis - pathology (130) 130
tryptase (124) 124
prognosis (120) 120
pathology (119) 119
child (117) 117
genetic aspects (110) 110
imatinib (110) 110
mastocytosis, systemic - diagnosis (110) 110
mast cells - immunology (108) 108
bone marrow - pathology (104) 104
mastocytosis - diagnosis (104) 104
kit (103) 103
mast-cells (103) 103
dermatology (101) 101
analysis (95) 95
mastocytosis, systemic - drug therapy (94) 94
point mutation (94) 94
bone marrow (93) 93
adolescent (92) 92
tumors (91) 91
immunohistochemistry (90) 90
benzamides (88) 88
acute myeloid-leukemia (87) 87
mutations (87) 87
mast cell (86) 86
protooncogene c-kit (86) 86
cell biology (84) 84
cutaneous mastocytosis (84) 84
catalytic domain (83) 83
abridged index medicus (80) 80
tyrosine kinase (80) 80
aged, 80 and over (78) 78
expression (78) 78
urticaria pigmentosa (78) 78
bone-marrow (77) 77
mastocytosis - immunology (77) 77
gene expression (76) 76
activation (75) 75
biopsy (75) 75
anaphylaxis (72) 72
mast-cell disease (72) 72
cancer (71) 71
identification (71) 71
mast cells - drug effects (71) 71
c-kit mutation (70) 70
diagnosis, differential (69) 69
criteria (68) 68
gastrointestinal stromal tumors (68) 68
pyrimidines - therapeutic use (67) 67
research (67) 67
disorders (66) 66
dna mutational analysis (66) 66
care and treatment (65) 65
child, preschool (65) 65
wild-type (65) 65
antineoplastic agents - therapeutic use (64) 64
mastocytosis, systemic - complications (63) 63
young adult (63) 63
receptor tyrosine kinase (62) 62
piperazines - therapeutic use (61) 61
skin (61) 61
tyrosine kinase inhibitor (61) 61
blood mononuclear-cells (60) 60
cell line, tumor (59) 59
cells (59) 59
patients (59) 59
infant (58) 58
skin - pathology (58) 58
signal transduction (57) 57
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1137) 1137
French (22) 22
German (13) 13
Polish (9) 9
Japanese (6) 6
Spanish (5) 5
Korean (3) 3
Russian (2) 2
Swedish (2) 2
Chinese (1) 1
Czech (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLOS GENETICS, ISSN 1553-7404, 03/2019, Volume 15, Issue 3, p. e1007967
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e85362
Systemic mastocytosis with associated hematologic clonal non-mast cell disease (SM-AHNMD) is a rare and heterogeneous subtype of SM and few studies on this... 
CRITERIA | KITD816V | POLYCYTHEMIA-VERA | LINEAGE DISEASES | MULTIDISCIPLINARY SCIENCES | Prognosis | Cell Count | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Mastocytosis, Systemic - diagnosis | Mastocytosis, Systemic - genetics | Neutropenia - complications | Neutropenia - diagnosis | Monocytes - pathology | Neutropenia - mortality | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Hematologic Neoplasms - complications | Neutropenia - genetics | Proto-Oncogene Proteins c-cbl - genetics | Hematologic Neoplasms - diagnosis | Repressor Proteins - genetics | Proto-Oncogene Proteins - genetics | DNA-Binding Proteins - genetics | Mastocytosis, Systemic - mortality | Adolescent | Survival Analysis | Aged | Hematologic Neoplasms - genetics | Mutation | Mastocytosis, Systemic - complications | Medical research | Mast cell disease | Analysis | Patient outcomes | Medicine, Experimental | Hemoglobin | Bones | Genetic aspects | Density | Splenomegaly | Mastocytosis | Disease | Laboratories | Liver | Leukemia | Multivariate analysis | Defects | Variables | Chronic myelomonocytic leukemia | Lesions | Neutropenia | Enlargement | Cell survival | Hematology | Patients | Survival | Studies | Monocytes | Medical prognosis | Tryptase | Bone mineral density | Blood diseases | Ascites | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0142450
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 774 - 777
Journal Article
Blood, ISSN 0006-4971, 02/2017, Volume 129, Issue 6, pp. 704 - 714
Molecular diagnostics has generated substantial dividends in dissecting the genetic basis of myeloid neoplasms with eosinophilia. The family of diseases... 
GROWTH-FACTOR RECEPTOR | BCR-JAK2 FUSION GENE | MYELOPROLIFERATIVE NEOPLASM | TYROSINE KINASE | TERM-FOLLOW-UP | IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | FIP1L1-PDGFRA FUSION | HEMATOLOGY | SYSTEMIC MASTOCYTOSIS | IMATINIB MESYLATE | PCM1-JAK2 FUSION | Eosinophilia - therapy | Oncogene Proteins, Fusion - metabolism | Leukemia - pathology | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Gene Expression Regulation, Neoplastic | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | fms-Like Tyrosine Kinase 3 | Antineoplastic Agents - therapeutic use | Myeloproliferative Disorders - pathology | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Receptor, Platelet-Derived Growth Factor beta - genetics | Myeloproliferative Disorders - genetics | Transplantation, Homologous | Eosinophilia - pathology | Hypereosinophilic Syndrome - diagnosis | Receptor, Platelet-Derived Growth Factor beta - antagonists & inhibitors | Receptor, Platelet-Derived Growth Factor alpha - antagonists & inhibitors | Janus Kinase 2 - metabolism | Eosinophilia - genetics | Hypereosinophilic Syndrome - pathology | Hypereosinophilic Syndrome - therapy | Eosinophilia - diagnosis | Janus Kinase 2 - antagonists & inhibitors | Leukemia - genetics | Receptor, Platelet-Derived Growth Factor beta - metabolism | Myeloproliferative Disorders - diagnosis | Proto-Oncogene Proteins c-abl - genetics | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Myeloproliferative Disorders - therapy | Janus Kinase 2 - genetics | Hematopoietic Stem Cell Transplantation | Leukemia - therapy | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Receptor, Platelet-Derived Growth Factor alpha - genetics | Leukemia - diagnosis | Proto-Oncogene Proteins c-abl - metabolism | Hypereosinophilic Syndrome - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2012, Volume 7, Issue 8, p. e43090
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 2006, Volume 117, Issue 6, pp. 1411 - 1414
Journal Article
Blood, ISSN 0006-4971, 07/2017, Volume 130, Issue 2, pp. 137 - 145
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2014, Volume 167, Issue 1, pp. 48 - 61
Systemic mastocytosis ( SM ) is a rare myeloproliferative disease without curative therapy. Despite clinical variability, the majority of patients harbour a... 
transgenesis | receptor tyrosine kinase | zebrafish | systemic mastocytosis | 816 | KIT | Receptor tyrosine kinase | Zebrafish | KIT D816V | Transgenesis | Systemic mastocytosis | D816V | RECEPTOR | MECHANISMS | ORGANISM | MAST-CELL LINEAGE | INFLAMMATION | IN-VIVO | LEUKEMIA | DNA-REPAIR | HEMATOLOGY | HEMATOPOIETIC STEM | Cell Cycle - genetics | Mastocytosis | Cell Adhesion Molecules - genetics | Kidney - pathology | Peptide Hydrolases - genetics | Humans | Embryo, Nonmammalian - metabolism | Apoptosis - genetics | Gene Expression Profiling | Mastocytosis, Systemic - genetics | Epithelial Cell Adhesion Molecule | DNA (Cytosine-5-)-Methyltransferases - metabolism | Gene Expression Regulation, Developmental | Antigens, Neoplasm - metabolism | Female | Proto-Oncogene Proteins c-kit - genetics | Gene Order | Disease Models, Animal | Peptide Hydrolases - metabolism | Antigens, Neoplasm - genetics | Gene Expression | Animals, Genetically Modified | DNA (Cytosine-5-)-Methyltransferase 1 | Zebrafish Proteins - metabolism | Hematopoiesis - genetics | Mast Cells - enzymology | Cell Adhesion Molecules - metabolism | Gene Expression Regulation, Enzymologic | DNA (Cytosine-5-)-Methyltransferases - genetics | Phenotype | Animals | Mutation | Zebrafish Proteins - genetics | Genetic Vectors | Animal genetic engineering | Mast cell disease | Analysis
Journal Article
Mediators of Inflammation, ISSN 0962-9351, 2015, Volume 2015, pp. 145293 - 16
Journal Article
Leukemia, ISSN 0887-6924, 01/2018, Volume 32, Issue 1, pp. 139 - 148
Journal Article